Citation: In. Bruce et al., DETECTION AND MODIFICATION OF RISK-FACTORS FOR CORONARY-ARTERY DISEASE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - A QUALITY IMPROVEMENT STUDY, Clinical and experimental rheumatology, 16(4), 1998, pp. 435-440
Authors:
CLARKSOLONINKA CA
BRUCE IN
SPITZER KA
NADLER J
LASKIN CA
Citation: Ca. Clarksoloninka et al., ANTI-B2-GLYCOPROTEIN-I AND ANTICARDIOLIPIN ANTIBODIES DISTINGUISH CLINICAL SUBSETS WITHIN THE ANTIPHOSPHOLIPID ANTIBODY SYNDROME, Arthritis and rheumatism, 41(9), 1998, pp. 813-813
Authors:
RAHMAN P
UROWITZ MB
GLADMAN DD
BRUCE IN
GENEST J
Citation: P. Rahman et al., CONTRIBUTION OF TRADITIONAL RISK-FACTORS TO CORONARY-ARTERY DISEASE (CAD) IN PATIENTS WITH SLE, Arthritis and rheumatism, 41(9), 1998, pp. 1118-1118
Authors:
BRUCE IN
ORLACCHIO A
GLADMAN DD
UROWITZ MB
SONG YQ
STGEORGEHYSLOP P
Citation: In. Bruce et al., NO ASSOCIATION BETWEEN APOLIPOPROTEIN-E GENOTYPE AND CORONARY-ARTERY DISEASE (CAD) OR COGNITIVE DYSFUNCTION IN SLE, Arthritis and rheumatism, 41(9), 1998, pp. 1518-1518
Authors:
SMYTH AE
BRUCE IN
MCGRANN S
ALLEN JA
BELL AL
Citation: Ae. Smyth et al., ENDOTHELIN-1 LEVELS AND DIGITAL VASCULAR-RESPONSES IN RAYNAUDS-PHENOMENON, Arthritis and rheumatism, 41(9), 1998, pp. 1742-1742
Citation: In. Bruce et al., PATIENT NONADHERENCE - AN IMPORTANT FACTOR CONTRIBUTING TO CHRONIC RENAL-INSUFFICIENCY (CRI) IN SLE, Arthritis and rheumatism, 41(9), 1998, pp. 1800-1800
Authors:
BRUCE IN
CLARKSOLONINKA CA
SPITZER KA
GLADMAN DD
UROWITZ MB
LASKIN CA
Citation: In. Bruce et al., ANTIBODIES TO BETA-2-GLYCOPROTEIN-1 IN PATIENTS WITH SLE DO NOT DISCRIMINATE THE ANTIPHOSPHOLIPID ANTIBODY SYNDROME (APS), Arthritis and rheumatism, 41(9), 1998, pp. 1801-1801
Citation: In. Bruce et al., HYPERURICEMIA IN PSORIATIC-ARTHRITIS (PSA) DOES NOT REFLECT THE EXTENT OF SKIN INVOLVEMENT, Arthritis and rheumatism, 41(9), 1998, pp. 1803-1803
Citation: Ad. Irvine et al., ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN LEUKOCYTOCLASTIC VASCULITIS - IN REPLY, Archives of dermatology, 134(2), 1998, pp. 239-240
Citation: In. Bruce et Ca. Laskin, SEX-HORMONES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A CONTROVERSY FOR MODERN TIMES, Journal of rheumatology, 24(8), 1997, pp. 1461-1463
Authors:
BRUCE IN
HARRIS CM
NUGENT A
MCDERMOTT BJ
JOHNSTON GD
BELL AL
Citation: In. Bruce et al., ENHANCED ENDOTHELIUM-DEPENDENT VASODILATOR RESPONSES IN PATIENTS WITHSYSTEMIC VASCULITIS, Scandinavian journal of rheumatology, 26(4), 1997, pp. 318-324
Citation: In. Bruce et Al. Bell, A COMPARISON OF 2 NOMENCLATURE SYSTEMS FOR PRIMARY SYSTEMIC VASCULITIS, British journal of rheumatology, 36(4), 1997, pp. 453-458
Citation: In. Bruce et al., AGE-RELATED-CHANGES IN NONRECEPTOR DEPENDENT GENERATION OF REACTIVE OXYGEN SPECIES FROM PHAGOCYTES OF HEALTHY-ADULTS, Mechanism of ageing and development, 94(1-3), 1997, pp. 135-144
Citation: In. Bruce et al., HIGH PREVALENCE OF MYOCARDIAL PERFUSION ABNORMALITIES IN WOMEN WITH SLE, Arthritis and rheumatism, 40(9), 1997, pp. 1132-1132
Citation: In. Bruce et al., RENAL-INSUFFICIENCY OR RENAL REPLACEMENT THERAPY (RRT) DOES NOT SUPPRESS DISEASE-ACTIVITY IN PATIENTS WITH SLE, Arthritis and rheumatism, 40(9), 1997, pp. 1134-1134
Citation: In. Bruce et al., FACTORS ASSOCIATED WITH MYOCARDIAL PERFUSION ABNORMALITIES IN WOMEN WITH SLE, Arthritis and rheumatism, 40(9), 1997, pp. 1627-1627
Citation: In. Bruce et Al. Bell, EFFECT OF CLASSIFICATION ON THE INCIDENCE OF POLYARTERITIS-NODOSA ANDMICROSCOPIC POLYANGIITIS - COMMENT, Arthritis and rheumatism, 40(6), 1997, pp. 1183-1183
Citation: Ad. Irvine et al., MICROSCOPIC POLYANGIITIS - DELINEATION OF A CUTANEOUS-LIMITED VARIANTASSOCIATED WITH ANTIMYELOPEROXIDASE AUTOANTIBODY, Archives of dermatology, 133(4), 1997, pp. 474-477
Citation: Ae. Smyth et al., TRANSVERSE MYELITIS - A COMPLICATION OF SYSTEMIC LUPUS-ERYTHEMATOSUS THAT IS ASSOCIATED WITH THE ANTIPHOSPHOLIPID SYNDROME, Ulster medical journal, 65(1), 1996, pp. 91-94